Medicare Enrolled

Dr. Josip Vukina, M.D.

Urology Physician · Raleigh, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
23 SUNNYBROOK RD, Raleigh, NC 27610
9193501570
In practice since 2012 (14 years)
NPI: 1790047280 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vukina from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vukina? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Vukina

Dr. Josip Vukina is an urology physician in Raleigh, NC, with 14 years of NPI registration. Based on federal Medicare data, Dr. Vukina performed 798 Medicare services across 656 unique beneficiaries.

Between the years covered by Open Payments, Dr. Vukina received a total of $1,742 from 20 pharmaceutical and/or device companies across 37 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Vukina is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ 798 Medicare services $1,742 industry payments

Medicare Practice Summary

Medicare Utilization ↗
798
Medicare services
Bottom 35% in NC for urology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
656
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~57 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
172 $2 $19
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
123 $90 $215
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
97 $63 $156
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
91 $117 $348
Urinalysis with microscopic exam
A urine test performed manually that includes examining the sample under a microscope to check for abnormalities.
65 $3 $19
Creatinine test (kidney function)
A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury.
65 $5 $24
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
48 $8 $74
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
41 $18 $184
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
39 $166 $773
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
25 $81 $1,887
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
18 $72 $256
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
14 $309 $961
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.9% high complexity
11.2% medium
84.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,742
Total received (2018-2024)
Avg $249/year across 7 years
Bottom 42% in NC for urology physician
20
Companies
37
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,493 (85.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$250 (14.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$361
2023
$390
2022
$480
2021
$4
2020
$210
2019
$177
2018
$121

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PROCEPT BioRobotics Corporation
$173
UROGEN PHARMA, INC.
$122
Ambu Inc.
$22
PFIZER INC.
$22
Sumitomo Pharma America, Inc.
$21
Top 3 companies account for 87.9% of 2024 payments
All-time payments by company (2018-2024) ›
Coloplast Corp
$295
PROCEPT BioRobotics Corporation
$173
Astellas Pharma US Inc
$165
Sumitomo Pharma America, Inc.
$153
Antares Pharma, Inc.
$131
Bayer Healthcare Pharmaceuticals Inc.
$122
UROGEN PHARMA, INC.
$122
Cook Medical LLC
$121
Boston Scientific Corporation
$107
Medtronic, Inc.
$77
UROVANT SCIENCES INC
$52
PFIZER INC.
$44
Endo Pharmaceuticals Inc.
$38
Teleflex LLC
$32
TOLMAR Pharmaceuticals, Inc.
$23
Ambu Inc.
$22
UroGen Pharma, Inc.
$20
Olympus America Inc.
$17
ABC Home Medical Supply, Inc.
$14
ABBVIE INC.
$14
Top 3 companies account for 36.3% of all-time payments
Associated products mentioned in payments ›
AQUABEAM SYSTEM · COOK MEDICAL SURGICAL · ELIGARD · GEMTESA · GENERAL ERECTILE DYSFUNCTION · INTERSTIM · JELMYTO · LUPRON DEPOT · NOCDURNA · Nubeqa · TITAN · TLANDO · URETERO-RENO FIBERSCOPE · UROLIFT · UroLift System · XIAFLEX · XTANDI · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Raleigh?
Compare urology physicians in the Raleigh area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
46
Per 100K population
4.0
County median income
$101,763
Nearest hospital
WAKEMED, RALEIGH CAMPUS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Vukina is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Vukina experienced with automated urinalysis?
Based on Medicare claims data, Dr. Vukina performed 172 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vukina receive payments from pharmaceutical companies?
Yes. Dr. Vukina received a total of $1,742 from 20 companies across 37 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vukina's costs compare to other urology physicians in Raleigh?
Dr. Vukina's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vukina) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →